Artiva Biotherapeutics, Inc. (ARTV) Net income 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$83.9MFY2025 · since FY2023: -$28.7M → -$83.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$83.9M | -28.3% |
| FY2024 | -$65.4M | -127.6% |
| FY2023 | -$28.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARTV financial trends
ARTV RevenueARTV Net marginARTV Gross profitARTV Gross marginARTV Operating incomeARTV Operating marginARTV Operating cash flowARTV Free cash flowARTV Capital expendituresARTV Return on equityARTV Stock buybacksARTV Dividends paidARTV Total assetsARTV Total liabilitiesARTV Shareholders’ equityARTV overview →